SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-23-001233
Filing Date
2023-09-07
Accepted
2023-09-07 16:30:10
Documents
12
Period of Report
2023-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 23879
  Complete submission text file 0001079973-23-001233.txt   195959

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20230831.xsd EX-101.SCH 3006
3 XBRL LABEL FILE opgn-20230831_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE opgn-20230831_pre.xml EX-101.PRE 22353
6 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3275
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 231242630
SIC: 8071 Services-Medical Laboratories